Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 CAD | +28.57% | +33.78% | -1.00% |
05-16 | Transcript : Rubicon Organics Inc., Q1 2024 Earnings Call, May 16, 2024 | |
05-16 | Rubicon Organics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 73.54 | 177.7 | 103.6 | 43.18 | 28.1 | 27.81 | - |
Enterprise Value (EV) 1 | 84.67 | 177.7 | 103.6 | 43.18 | 28.1 | 27.81 | 27.81 |
P/E ratio | -4.97 x | -10.6 x | -7.12 x | -11 x | -16.7 x | -12.4 x | -49.5 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | 18.9 x | 4.58 x | 1.22 x | 0.7 x | 0.64 x | 0.57 x |
EV / Revenue | - | 18.9 x | 4.58 x | 1.22 x | 0.7 x | 0.64 x | 0.57 x |
EV / EBITDA | -11.1 x | -16 x | -12.9 x | 22.6 x | 6.43 x | 7.95 x | 3.97 x |
EV / FCF | - | - | -6,497,572 x | - | - | - | - |
FCF Yield | - | - | -0% | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 39,966 | 49,090 | 55,983 | 56,075 | 56,192 | 56,192 | - |
Reference price 2 | 1.840 | 3.620 | 1.850 | 0.7700 | 0.5000 | 0.4950 | 0.4950 |
Announcement Date | 4/21/20 | 4/6/21 | 4/19/22 | 3/31/23 | 3/28/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 9.387 | 22.61 | 35.52 | 40.12 | 43.2 | 48.4 |
EBITDA 1 | -6.654 | -11.08 | -8.006 | 1.908 | 4.371 | 3.5 | 7 |
EBIT | -9.631 | -11.99 | -13.26 | - | - | - | - |
Operating Margin | - | -127.72% | -58.63% | - | - | - | - |
Earnings before Tax (EBT) | -11.18 | - | -14.52 | - | - | - | - |
Net income 1 | -14.27 | -14.98 | -14.52 | -3.856 | -1.824 | -2.8 | -0.4 |
Net margin | - | -159.61% | -64.22% | -10.86% | -4.55% | -6.48% | -0.83% |
EPS 2 | -0.3700 | -0.3400 | -0.2600 | -0.0700 | -0.0300 | -0.0400 | -0.0100 |
Free Cash Flow | - | - | -15.94 | - | - | - | - |
FCF margin | - | - | -70.49% | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/21/20 | 4/6/21 | 4/19/22 | 3/31/23 | 3/28/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.815 | 5.148 | 8.835 | 10.54 | 10.99 | 8.8 | 11.28 | 10.04 | 9.993 | 8.89 | 10 | 11.7 | 12.6 | 10.7 | 11.7 |
EBITDA 1 | -0.5705 | -1.521 | 0.2612 | 1.897 | 1.266 | 0.1687 | 1.768 | 1.142 | 1.293 | -0.4232 | 0.7 | 1.5 | 1.8 | 1 | 1.7 |
EBIT | -1.369 | -1.129 | -0.944 | 2.202 | -2.717 | -0.3045 | - | - | - | - | - | - | - | - | - |
Operating Margin | -20.09% | -21.93% | -10.68% | 20.89% | -24.72% | -3.46% | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | -1.59 | -1.492 | -1.232 | 2.026 | -3.158 | -0.575 | - | - | - | - | - | - | - | - | - |
Net income | -1.59 | -1.492 | -1.232 | 2.026 | -3.158 | -0.575 | - | - | - | - | - | - | - | - | - |
Net margin | -23.34% | -28.97% | -13.95% | 19.21% | -28.73% | -6.53% | - | - | - | - | - | - | - | - | - |
EPS | -0.0200 | -0.0300 | -0.0200 | 0.0400 | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 4/19/22 | 5/24/22 | 8/13/22 | 11/15/22 | 3/31/23 | 5/23/23 | 9/28/23 | 12/28/23 | 3/28/24 | - | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | 11.1 | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -1.673 x | - | - | - | - | - | - |
Free Cash Flow | - | - | -15.9 | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | 7.94 | - | 5.5 | - | - | - | - |
Capex / Sales | - | - | 24.31% | - | - | - | - |
Announcement Date | 4/21/20 | 4/6/21 | 4/19/22 | 3/31/23 | 3/28/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.00% | 15.8M | |
+11.11% | 261M | |
-3.09% | 211M | |
+22.67% | 167M | |
+21.30% | 130M | |
+300.00% | 121M | |
-57.00% | 103M | |
-28.57% | 96.6M | |
+71.19% | 96.17M | |
-15.38% | 66.82M |
- Stock Market
- Equities
- ROMJ Stock
- Financials Rubicon Organics Inc.